Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Project Element Element Description

Project Title

Project Title

Molecular consequences of strong effect ASD mutations including 16p11.2

Principal Investigator

Principal Investigator

Gusella, James

Description

Description

Understanding how genetic defects that cause autism lead to abnormal neurodevelopment is critical to developing mechanism-based treatments. One particularly important question is whether different genetic defects produce autism traits in completely different ways, or whether alterations in different genes trigger a cascade of cellular changes that overlap and ultimately lead to autism by the same biochemical mechanism. JamesGusella and his colleagues at Massachusetts General Hospital aim to explore this question by using cutting-edge genome modification techniques to compare the effects of different autism-linked genetic traits in cultured human stem cells and neurons. In a small-scale preliminary study using interference with messenger RNA, Gusella and his group suppressed expression of several autism genes whose normal function is to help regulate the timing and level of expression of other genes throughout the human genome1. The results indicated that reducing the expression of some autism genes in neuronal progenitor cells alters the expression of many other autism genes. To better define the gene networks involved in autism, the researchers are now applying a new genome editing technique that introduces precise mutations into selected autism genes in human stem cells, and are then measuring genome-wide expression changes. These comparisons are being done in authentic human cells with identical genomes (other than the introduced mutation) at the neural progenitor stage and throughout their development into mature nerve cells, a process of fundamental relevance to neurodevelopment in autism. The results of this analysis will test the hypothesis that different autism genes produce the disorder by leading to the same kinds of changes in nerve cell development and that this biochemical mechanism is also triggered by the common deletion mutation of chromosomal region 16p11.2. Identification of a shared disease process despite different initial triggering genes would allow researchers to target that shared process for the development of interventions that would apply broadly in autism. References: 1. Sugathan A. et al. Proc. Natl. Acad. Sci. USA 111, E4468-4477 (2014) PubMed

Funder

Funder

Simons Foundation

Funding Country

Funding Country

United States

Fiscal Year Funding

Fiscal Year Funding

250000

Current Award Period

Current Award Period

2014-2017

Strategic Plan Question

Strategic Plan Question

Question 2: What is the Biology Underlying ASD?

Funder’s Project Link

Funder’s Project Link

External Project Page Go to website disclaimer

Institution

Institution

Massachusetts General Hospital

Institute Location

Institute Location

United States

Project Number

Project Number

308955

Government or Private

Government or Private

Private

History/Related Projects

History/Related Projects

Molecular consequences of strong effect ASD mutations including 16p11.2 | 250000 | 2015 | 308955
Molecular consequences of strong effect ASD mutations including 16p11.2 | 125000 | 2014 | 308955
Molecular consequences of strong effect ASD mutations including 16p11.2 | 225000 | 2017 | 308955
Molecular consequences of strong effect ASD mutations including 16p11.2 | 100000 | 2018 | 308955

Back to Top